EPISODE · Dec 14, 2025 · 1 MIN
Obutinib treatment for SLE phase IIb study achieves primary endpoint and is approved for
from DTnewswire · host DTnewswire
Smf5Yv7iSAZW7lGwgunC
NOW PLAYING
Obutinib treatment for SLE phase IIb study achieves primary endpoint and is approved for
0:00
1:51
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of DTnewswire?
This episode is 1 minute long.
When was this DTnewswire episode published?
This episode was published on December 14, 2025.
What is this episode about?
Smf5Yv7iSAZW7lGwgunC
Can I download this DTnewswire episode?
Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!